Current estimates of transfusion safety worldwide

Developments in Biologicals

Volumn 120, Issue , 2005, Pages 3-10

  Dodd, R Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; HEALTH; HEALTH CARE PLANNING; HUMAN; SAFETY;

BLOOD DONORS; BLOOD TRANSFUSION; HEALTH PRIORITIES; HUMANS; SAFETY; WORLD HEALTH;

EID: 27744464224     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (11)

1. Pealer LN, Marfin AA, Petersen LR et al: Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
2. Jackson BR, Busch MP, Stramer SL et al: The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-729.
3. Safe blood and safer sex. Education and counselling. AIDS Action 1996; 4-5.
4. Bassett MT, McFarland WC, Ray S et al: Risk factors for HIV infection at enrollment in an urban male factory cohort in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 287-293.
5. Mbizvo MT, Ray S, Bassett M et al: Condom use and the risk of HIV infection: who is being protected? Cent Afr J Med 1994; 40: 294-299.
6. Dhingra N: Blood safety in the developing world and WHO initiatives. Vox Sang 2002; 83 Suppl 1: 173-177.
7. Schmunis GA, Zicker F, Pinheiro F et al: Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis 1998; 4: 5-11.
8. Dodd RY, Notari EP, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-979.
9. Glynn SA, Kleinman SH, Wright DJ et al: International application of the incidence rate/window period model. Transfusion 2002; 42: 966-972.
10. Fang CT, Field SP, Busch MP et al: Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang 2003; 85: 9-19.
11. Schmuñis GA, Zicker F, Segura EL et al: Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion 2000; 40: 1048-1053.